Kyle Yang, a biotechnology equity research associate and a CFA charterholder, has an exceptional background in biotechnology and finance. He completed his Bachelor's degree in Chemistry at ShanghaiTech University and a Bachelor's degree in Molecular and Cellular Biology at the University of California, Berkeley. He went on to study and gain his Master's Degree in Biotechnology at Columbia University in the City of New York. Kyle has held various positions throughout his career, including Senior Investment Analyst at SOSV, Intern at Bain & Company, and Marketing Intern at Roche Pharmaceuticals. He was also a former Student Venture Associate at Columbia Technology Ventures. Kyle's expertise lies in inflammatory diseases and radioligand therapy, having worked as a Biotech Equity Research Associate with a focus on these areas for Oppenheimer & Co. Inc.